Table 3 Prevalence of HIV, hepatitis B and hepatitis C *.
Condition—% (95% CI) | Total | Women | Men |
|---|---|---|---|
Confirmed HIV infection | 2.4 (1.3–4.2) | 3.20 (1.6–6.1) | 1.08 (0.04–4.1) |
HBsAg positive | 3.4 (2.1–5.5) | 2.84 (1.4–5.6) | 4.30 (2.1–8.4) |
Anti-HBc (IgG + IgM) positive | 36.5 (32.3–41.0) | 34.8 (29.4–40.5) | 39.3 (32.5–46.4) |
Anti-HBc (IgM) positive | 0.43 (0.0–1.7) | 0.00 (0.0–1.6) | 1.08 (0.04–4.1) |
Confirmed hepatitis C virus infection | 0.00 (0.0–0.9) | 0.00 (0.0–1.6) | 0.00 (0.00–4.1) |
